Status:
UNKNOWN
Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
Lead Sponsor:
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Conditions:
COVID-19
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
In December 2019, Wuhan, in Hubei province, China, became the center of an outbreak of pneumonia of unknown cause. In a short time, Chinese scientists had shared the genome information of a novel coro...
Detailed Description
The new coronavirus (COVID-19) \[1\] belongs to the new beta coronavirus. Current research shows that it has 85% homology with bat SARS-like coronavirus (bat-SL-CoVZC45), but its genetic characteristi...
Eligibility Criteria
Inclusion
- Aged \>=18 years;
- Novel coronavirus pneumonia patients diagnosed by pathogenic testing;
- The patient himself participated in the study voluntarily, agreed and signed the informed consent.
Exclusion
- Meet the diagnostic criteria for severe new-type coronavirus infection pneumonia;
- Severe primary diseases that affect survival, including: uncontrolled malignant tumors, hematological diseases, and HIV that have not been metastasized in multiple places;
- Obstructive pneumonia, pulmonary interstitial fibrosis, alveolar proteinosis, and allergic alveolitis caused by lung tumors;
- Women who are breastfeeding or pregnant;
- Those who are known to be allergic to the ingredients contained in the research medication, or patients with allergies;
- Those who have continued to use immunosuppressive agents or organ transplants in the past 6 months;
- Patients who have participated in other drug clinical trials within 3 months before the screening test;
- The investigator judges that he or she cannot complete or should not participate in the study (expected death within 48 hours, and the patient refuses active treatment)
Key Trial Info
Start Date :
March 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 14 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04295551
Start Date
March 14 2020
End Date
April 14 2021
Last Update
March 4 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.